Table 2.
Clinical indices | First term of study | Second term of study | |||
---|---|---|---|---|---|
Group 1 (n = 24) | Group 2 (n = 14) | Group 1 (n = 24) | Group 2 (n = 14) | ||
Subgroup 1A (n = 18) | Subgroup 1B (n = 6) | ||||
TNF-α (pg/ml) | 5.52 ± 0.94 | 5.42 ± 0.87 | 2.34 ± 0.87* | 5.49 ± 0.84 | 5.27 ± 0.94 |
IL-1β (pg/ml) | 20.74 ± 2.71 | 20.16 ± 2.46 | 6.83 ± 1.51* | 19.86 ± 1.98 | 19.63 ± 2.21 |
IL-17 (pg/ml) | 17.58 ± 3.23 | 17.23 ± 3.15 | 9.35 ± 1.71* | 16.62 ± 2.29 | 15.93 ± 2.37 |
* The difference between the first and the second term is statistically significant in a given group of patients